Protective effect and mechanism of genistein on etoposide-induced chondrocyte senescence

Acta Universitatis Medicinalis Anhui     font:big middle small

Fund programs: Health Research Project of Anhui Province (No. AHWJ2024Aa40016); Occupational Medicine and Health Joint Research Project from Institute of Health and Medicine, Hefei Comprehensive National Science Center (No. OMH-2023-03); Natural Science Foundation of Anhui Province (No. 2208085MH215); Scientific Research Project of Inheritance and Innovation of Traditional Chinese Medicine in Anhui Province.(No. 2020cczd05)

Authors:Wang Jinhong1,2, Chen Tianyu1,2, Mao Lifang1,2, Zhao Yingjie1,2, Zhou Renpeng1,2, Hu Wei1,2, Lu Chao1,3

Keywords:genistein; Prdx6; chondrocytes; senescence; molecular docking; etoposide

DOI:10.19405/j.cnki.issn1000-1492.2026.04.007

〔Abstract〕 Objective To investigate the protective effect of genistein (Gen) on etoposide-induced chondrocyte senescence and its underlying mechanism.Methods The C28/I2 cell line was treated with different concentrations of Gen and etoposide, and the cell viability was detected by the CCK-8 assay. The senescence model of C28/I2 chondrocytes was induced by etoposide, with Gen intervention. Senescence-associated β-galactosidase (SA-β-gal) staining was performed to detect the senescence-positive rate and staining characteristics of chondrocytes. The expressions of peroxiredoxin 6 (Prdx6), cyclin-dependent kinaseto clarify the functional necessity of Prdx6.Results Compared with the etoposide group, the C28/I2 chondrocyte viability significantly increased (P<0.01), the expression ofsenescence-associated proteins p21 and p16 decreased (P<0.01, P<0.05), the expression of senescence-associated genes p21 and p16 reduced (both P<0.01), the fluorescence intensity of senescence-associated proteins p21 and p16 was diminished (P<0.05, P<0.01), and the proportion of SA-β-gal-positive cells decreased (P<0.01) in the Gen+etoposide group. Compared with the Control group, the expression of Prdx6 was downregulated in the etoposide group (P<0.05). Compared with the etoposide group, the expression of Prdx6 was upregulated in the Gen+etoposide group (P<0.01). Compared with the Control group, the GPx activity significantly decreased in the si-Prdx6 group (P<0.01). Furthermore, compared with the si-Prdx6 group, the GPx activity increased in the si-Prdx6+Gen group (P<0.05). Molecular docking results revealed that Gen formed hydrogen bond interactions with the active site of Prdx6. After Prdx6 knockdown, the expression of senescence-associated genes p21 and p16 and the fluorescence intensity of senescence-associated proteins p21 and p16 both increased in the Gen+etoposide+si-Prdx6 group (both P<0.01).Conclusion Gen can inhibit etoposide-induced senescence of C28/I2 chondrocytes by upregulating the expression of Prdx6. This study provides potential drug targets and experimental basis for the prevention and treatment of chondrocyte senescence-related diseases.